Year |
Citation |
Score |
2022 |
Mediavilla T, Özalay Ö, Estévez-Silva HM, Frias B, Orädd G, Sultan FR, Brozzoli C, Garzón B, Lövdén M, Marcellino DJ. Learning-related contraction of gray matter in rodent sensorimotor cortex is associated with adaptive myelination. Elife. 11. PMID 36350292 DOI: 10.7554/eLife.77432 |
0.698 |
|
2022 |
Mao H, Mediavilla T, Estévez-Silva H, Marcellino D, Sultan F. Increase of vesicular glutamate transporter 2 co-expression in the deep cerebellar nuclei related to skilled reach learning. Brain Research. 1782: 147842. PMID 35192848 DOI: 10.1016/j.brainres.2022.147842 |
0.692 |
|
2022 |
Giacobbo BL, Özalay Ö, Mediavilla T, Ericsson M, Axelsson J, Rieckmann A, Sultan F, Marcellino D. The Aged Striatum: Evidence of Molecular and Structural Changes Using a Longitudinal Multimodal Approach in Mice. Frontiers in Aging Neuroscience. 14: 795132. PMID 35140600 DOI: 10.3389/fnagi.2022.795132 |
0.722 |
|
2022 |
Estévez-Silva HM, Mediavilla T, Giacobbo BL, Liu X, Sultan FR, Marcellino DJ. Pridopidine modifies disease phenotype in a SOD1 mouse model of amyotrophic lateral sclerosis. The European Journal of Neuroscience. PMID 35080077 DOI: 10.1111/ejn.15608 |
0.702 |
|
2021 |
Giacobbo BL, Mediavilla T, Marcellino DJ, Sultan F. Metabolic changes in an animal model of amyotrophic lateral sclerosis evaluated by [F]-FDG positron emission tomography. Translational Neurodegeneration. 10: 21. PMID 34162436 DOI: 10.1186/s40035-021-00246-1 |
0.686 |
|
2019 |
Kolan SS, Lidström T, Mediavilla T, Dernstedt A, Degerman S, Hultdin M, Björk K, Marcellino D, Forsell MNE. Growth-inhibition of cell lines derived from B cell lymphomas through antagonism of serotonin receptor signaling. Scientific Reports. 9: 4276. PMID 30862884 DOI: 10.1038/s41598-019-40825-x |
0.709 |
|
2014 |
Sahlholm K, Marcellino D, Nilsson J, Ögren SO, Fuxe K, Århem P. Typical and atypical antipsychotics do not differ markedly in their reversibility of antagonism of the dopamine D2 receptor. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 149-55. PMID 24074141 DOI: 10.1017/S1461145713000801 |
0.378 |
|
2013 |
Frankowska M, Marcellino D, Adamczyk P, Filip M, Fuxe K. Effects of cocaine self-administration and extinction on D2 -like and A2A receptor recognition and D2 -like/Gi protein coupling in rat striatum. Addiction Biology. 18: 455-66. PMID 22500978 DOI: 10.1111/j.1369-1600.2012.00452.x |
0.339 |
|
2012 |
Sahlholm K, Nilsson J, Marcellino D, Fuxe K, Arhem P. Voltage sensitivities and deactivation kinetics of histamine H₃ and H₄ receptors. Biochimica Et Biophysica Acta. 1818: 3081-9. PMID 22885137 DOI: 10.1016/J.Bbamem.2012.07.027 |
0.406 |
|
2012 |
Ferraro L, Frankowska M, Marcellino D, Zaniewska M, Beggiato S, Filip M, Tomasini MC, Antonelli T, Tanganelli S, Fuxe K. A novel mechanism of cocaine to enhance dopamine d2-like receptor mediated neurochemical and behavioral effects. An in vivo and in vitro study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1856-66. PMID 22453136 DOI: 10.1038/npp.2012.33 |
0.344 |
|
2012 |
Marcellino D, Kehr J, Agnati LF, Fuxe K. Increased affinity of dopamine for D(2) -like versus D(1) -like receptors. Relevance for volume transmission in interpreting PET findings. Synapse (New York, N.Y.). 66: 196-203. PMID 22034017 DOI: 10.1002/syn.21501 |
0.437 |
|
2011 |
Sahlholm K, Barchad-Avitzur O, Marcellino D, Gómez-Soler M, Fuxe K, Ciruela F, Arhem P. Agonist-specific voltage sensitivity at the dopamine D2S receptor--molecular determinants and relevance to therapeutic ligands. Neuropharmacology. 61: 937-49. PMID 21752340 DOI: 10.1016/J.Neuropharm.2011.06.022 |
0.424 |
|
2010 |
Borroto-Escuela DO, Romero-Fernandez W, Tarakanov AO, Gómez-Soler M, Corrales F, Marcellino D, Narvaez M, Frankowska M, Flajolet M, Heintz N, Agnati LF, Ciruela F, Fuxe K. Characterization of the A2AR-D2R interface: focus on the role of the C-terminal tail and the transmembrane helices. Biochemical and Biophysical Research Communications. 402: 801-7. PMID 21040702 DOI: 10.1016/J.Bbrc.2010.10.122 |
0.58 |
|
2010 |
Navarro G, Moreno E, Aymerich M, Marcellino D, McCormick PJ, Mallol J, Cortés A, Casadó V, Canela EI, Ortiz J, Fuxe K, LluÃs C, Ferré S, Franco R. Direct involvement of sigma-1 receptors in the dopamine D1 receptor-mediated effects of cocaine. Proceedings of the National Academy of Sciences of the United States of America. 107: 18676-81. PMID 20956312 DOI: 10.1073/Pnas.1008911107 |
0.399 |
|
2010 |
Borroto-Escuela DO, Romero-Fernandez W, Tarakanov AO, Marcellino D, Ciruela F, Agnati LF, Fuxe K. Dopamine D2 and 5-hydroxytryptamine 5-HT(â‚‚A) receptors assemble into functionally interacting heteromers. Biochemical and Biophysical Research Communications. 401: 605-10. PMID 20888323 DOI: 10.1016/J.Bbrc.2010.09.110 |
0.585 |
|
2010 |
Fuxe K, Marcellino D, Borroto-Escuela DO, Frankowska M, Ferraro L, Guidolin D, Ciruela F, Agnati LF. The changing world of G protein-coupled receptors: from monomers to dimers and receptor mosaics with allosteric receptor-receptor interactions. Journal of Receptor and Signal Transduction Research. 30: 272-83. PMID 20684666 DOI: 10.3109/10799893.2010.506191 |
0.605 |
|
2010 |
Marcellino D, Lindqvist E, Schneider M, Müller CE, Fuxe K, Olson L, Galter D. Chronic A2A antagonist treatment alleviates parkinsonian locomotor deficiency in MitoPark mice. Neurobiology of Disease. 40: 460-6. PMID 20656029 DOI: 10.1016/J.Nbd.2010.07.008 |
0.393 |
|
2010 |
Marcellino D, Suárez-Boomgaard D, Sánchez-Reina MD, Aguirre JA, Yoshitake T, Yoshitake S, Hagman B, Kehr J, Agnati LF, Fuxe K, Rivera A. On the role of P2X(7) receptors in dopamine nerve cell degeneration in a rat model of Parkinson's disease: studies with the P2X(7) receptor antagonist A-438079. Journal of Neural Transmission (Vienna, Austria : 1996). 117: 681-7. PMID 20387084 DOI: 10.1007/s00702-010-0400-0 |
0.407 |
|
2010 |
Ferraro L, Beggiato S, Marcellino D, Frankowska M, Filip M, Agnati LF, Antonelli T, Tomasini MC, Tanganelli S, Fuxe K. Nanomolar concentrations of cocaine enhance D2-like agonist-induced inhibition of the K+-evoked [3H]-dopamine efflux from rat striatal synaptosomes: a novel action of cocaine. Journal of Neural Transmission (Vienna, Austria : 1996). 117: 593-7. PMID 20354886 DOI: 10.1007/s00702-010-0389-4 |
0.319 |
|
2010 |
Marcellino D, Navarro G, Sahlholm K, Nilsson J, Agnati LF, Canela EI, LluÃs C, Ã…rhem P, Franco R, Fuxe K. Cocaine produces D2R-mediated conformational changes in the adenosine A(2A)R-dopamine D2R heteromer. Biochemical and Biophysical Research Communications. 394: 988-92. PMID 20307491 DOI: 10.1016/J.Bbrc.2010.03.104 |
0.384 |
|
2010 |
Borroto-Escuela DO, Marcellino D, Narvaez M, Flajolet M, Heintz N, Agnati L, Ciruela F, Fuxe K. A serine point mutation in the adenosine A2AR C-terminal tail reduces receptor heteromerization and allosteric modulation of the dopamine D2R. Biochemical and Biophysical Research Communications. 394: 222-7. PMID 20197060 DOI: 10.1016/J.Bbrc.2010.02.168 |
0.595 |
|
2010 |
Borroto-Escuela DO, Narvaez M, Marcellino D, Parrado C, Narvaez JA, Tarakanov AO, Agnati LF, DÃaz-Cabiale Z, Fuxe K. Galanin receptor-1 modulates 5-hydroxtryptamine-1A signaling via heterodimerization. Biochemical and Biophysical Research Communications. 393: 767-72. PMID 20171159 DOI: 10.1016/J.Bbrc.2010.02.078 |
0.618 |
|
2010 |
Genedani S, Carone C, Guidolin D, Filaferro M, Marcellino D, Fuxe K, Agnati LF. Differential sensitivity of A2A and especially D2 receptor trafficking to cocaine compared with lipid rafts in cotransfected CHO cell lines. Novel actions of cocaine independent of the DA transporter. Journal of Molecular Neuroscience : Mn. 41: 347-57. PMID 20143275 DOI: 10.1007/s12031-010-9328-y |
0.371 |
|
2010 |
Fuxe K, Marcellino D, Leo G, Agnati LF. Molecular integration via allosteric interactions in receptor heteromers. A working hypothesis. Current Opinion in Pharmacology. 10: 14-22. PMID 19942481 DOI: 10.1016/j.coph.2009.10.010 |
0.436 |
|
2010 |
Fuxe K, Dahlström AB, Jonsson G, Marcellino D, Guescini M, Dam M, Manger P, Agnati L. The discovery of central monoamine neurons gave volume transmission to the wired brain. Progress in Neurobiology. 90: 82-100. PMID 19853007 DOI: 10.1016/j.pneurobio.2009.10.012 |
0.354 |
|
2010 |
de la Mora MP, Gallegos-Cari A, Arizmendi-GarcÃa Y, Marcellino D, Fuxe K. Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: Structural and functional analysis. Progress in Neurobiology. 90: 198-216. PMID 19853006 DOI: 10.1016/j.pneurobio.2009.10.010 |
0.421 |
|
2009 |
Fuxe K, Marcellino D, Guidolin D, Woods AS, Agnati L. Brain receptor mosaics and their intramembrane receptor-receptor interactions: molecular integration in transmission and novel targets for drug development. Journal of Acupuncture and Meridian Studies. 2: 1-25. PMID 20633470 DOI: 10.1016/S2005-2901(09)60011-X |
0.41 |
|
2009 |
Navarro G, Aymerich MS, Marcellino D, Cortés A, Casadó V, Mallol J, Canela EI, Agnati L, Woods AS, Fuxe K, LluÃs C, Lanciego JL, Ferré S, Franco R. Interactions between calmodulin, adenosine A2A, and dopamine D2 receptors. The Journal of Biological Chemistry. 284: 28058-68. PMID 19632986 DOI: 10.1074/Jbc.M109.034231 |
0.427 |
|
2009 |
Fuxe K, Marcellino D, Woods AS, Giuseppina L, Antonelli T, Ferraro L, Tanganelli S, Agnati LF. Integrated signaling in heterodimers and receptor mosaics of different types of GPCRs of the forebrain: relevance for schizophrenia. Journal of Neural Transmission (Vienna, Austria : 1996). 116: 923-39. PMID 19156349 DOI: 10.1007/S00702-008-0174-9 |
0.451 |
|
2008 |
Fuxe K, Marcellino D, Guidolin D, Woods AS, Agnati LF. Heterodimers and receptor mosaics of different types of G-protein-coupled receptors. Physiology (Bethesda, Md.). 23: 322-32. PMID 19074740 DOI: 10.1152/Physiol.00028.2008 |
0.397 |
|
2008 |
Sahlholm K, Marcellino D, Nilsson J, Fuxe K, Arhem P. Voltage-sensitivity at the human dopamine D2S receptor is agonist-specific. Biochemical and Biophysical Research Communications. 377: 1216-21. PMID 18983826 DOI: 10.1016/J.Bbrc.2008.10.117 |
0.387 |
|
2008 |
Sahlholm K, Marcellino D, Nilsson J, Fuxe K, Arhem P. Differential voltage-sensitivity of D2-like dopamine receptors. Biochemical and Biophysical Research Communications. 374: 496-501. PMID 18652803 DOI: 10.1016/J.Bbrc.2008.07.052 |
0.427 |
|
2008 |
Marcellino D, Ferré S, Casadó V, Cortés A, Le Foll B, Mazzola C, Drago F, Saur O, Stark H, Soriano A, Barnes C, Goldberg SR, Lluis C, Fuxe K, Franco R. Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum. The Journal of Biological Chemistry. 283: 26016-25. PMID 18644790 DOI: 10.1074/jbc.M710349200 |
0.436 |
|
2008 |
Woods AS, Marcellino D, Jackson SN, Franco R, Ferré S, Agnati LF, Fuxe K. How calmodulin interacts with the adenosine A(2A) and the dopamine D(2) receptors. Journal of Proteome Research. 7: 3428-34. PMID 18590318 DOI: 10.1021/Pr8001782 |
0.437 |
|
2008 |
Sahlholm K, Nilsson J, Marcellino D, Fuxe K, Arhem P. Electrophysiology-based analysis of human histamine H(4) receptor pharmacology using GIRK channel coupling in Xenopus oocytes. European Journal of Pharmacology. 591: 52-8. PMID 18582456 DOI: 10.1016/J.Ejphar.2008.06.029 |
0.389 |
|
2008 |
Sahlholm K, Nilsson J, Marcellino D, Fuxe K, Arhem P. Voltage-dependence of the human dopamine D2 receptor. Synapse (New York, N.Y.). 62: 476-80. PMID 18361445 DOI: 10.1002/Syn.20509 |
0.443 |
|
2008 |
Marcellino D, Carriba P, Filip M, Borgkvist A, Frankowska M, Bellido I, Tanganelli S, Müller CE, Fisone G, Lluis C, Agnati LF, Franco R, Fuxe K. Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis. Neuropharmacology. 54: 815-23. PMID 18262573 DOI: 10.1016/J.Neuropharm.2007.12.011 |
0.451 |
|
2008 |
Borgkvist A, Marcellino D, Fuxe K, Greengard P, Fisone G. Regulation of DARPP-32 phosphorylation by Delta9-tetrahydrocannabinol. Neuropharmacology. 54: 31-5. PMID 17686497 DOI: 10.1016/J.Neuropharm.2007.06.025 |
0.402 |
|
2007 |
Fuxe K, Marcellino D, Genedani S, Agnati L. Adenosine A(2A) receptors, dopamine D(2) receptors and their interactions in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 1990-2017. PMID 17618524 DOI: 10.1002/mds.21440 |
0.427 |
|
2007 |
Sahlholm K, Nilsson J, Marcellino D, Fuxe K, Arhem P. The human histamine H3 receptor couples to GIRK channels in Xenopus oocytes. European Journal of Pharmacology. 567: 206-10. PMID 17537431 DOI: 10.1016/J.Ejphar.2007.04.032 |
0.37 |
|
2007 |
Fuxe K, Dahlström A, Höistad M, Marcellino D, Jansson A, Rivera A, Diaz-Cabiale Z, Jacobsen K, Tinner-Staines B, Hagman B, Leo G, Staines W, Guidolin D, Kehr J, Genedani S, et al. From the Golgi-Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: wiring and volume transmission. Brain Research Reviews. 55: 17-54. PMID 17433836 DOI: 10.1016/J.Brainresrev.2007.02.009 |
0.382 |
|
2007 |
Marcellino D, Roberts DC, Navarro G, Filip M, Agnati L, LluÃs C, Franco R, Fuxe K. Increase in A2A receptors in the nucleus accumbens after extended cocaine self-administration and its disappearance after cocaine withdrawal. Brain Research. 1143: 208-20. PMID 17320828 DOI: 10.1016/j.brainres.2007.01.079 |
0.379 |
|
2005 |
Fuxe K, Ferré S, Canals M, Torvinen M, Terasmaa A, Marcellino D, Goldberg SR, Staines W, Jacobsen KX, Lluis C, Woods AS, Agnati LF, Franco R. Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function. Journal of Molecular Neuroscience : Mn. 26: 209-20. PMID 16012194 DOI: 10.1385/Jmn:26:2-3:209 |
0.423 |
|
2005 |
Torvinen M, Torri C, Tombesi A, Marcellino D, Watson S, Lluis C, Franco R, Fuxe K, Agnati LF. Trafficking of adenosine A2A and dopamine D2 receptors. Journal of Molecular Neuroscience : Mn. 25: 191-200. PMID 15784967 DOI: 10.1385/JMN:25:2:191 |
0.433 |
|
2005 |
Torvinen M, Marcellino D, Canals M, Agnati LF, Lluis C, Franco R, Fuxe K. Adenosine A2A receptor and dopamine D3 receptor interactions: evidence of functional A2A/D3 heteromeric complexes. Molecular Pharmacology. 67: 400-7. PMID 15539641 DOI: 10.1124/mol.104.003376 |
0.438 |
|
2004 |
Ciruela F, Burgueño J, Casadó V, Canals M, Marcellino D, Goldberg SR, Bader M, Fuxe K, Agnati LF, Lluis C, Franco R, Ferré S, Woods AS. Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors. Analytical Chemistry. 76: 5354-63. PMID 15362892 DOI: 10.1021/Ac049295F |
0.405 |
|
2004 |
Ferré S, Ciruela F, Canals M, Marcellino D, Burgueno J, Casadó V, Hillion J, Torvinen M, Fanelli F, Benedetti Pd Pd, Goldberg SR, Bouvier M, Fuxe K, Agnati LF, Lluis C, et al. Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders. Parkinsonism & Related Disorders. 10: 265-71. PMID 15196504 DOI: 10.1016/J.Parkreldis.2004.02.014 |
0.45 |
|
2004 |
Canals M, Burgueño J, Marcellino D, Cabello N, Canela EI, Mallol J, Agnati L, Ferré S, Bouvier M, Fuxe K, Ciruela F, Lluis C, Franco R. Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. Journal of Neurochemistry. 88: 726-34. PMID 14720222 DOI: 10.1046/J.1471-4159.2003.02200.X |
0.429 |
|
2003 |
Canals M, Marcellino D, Fanelli F, Ciruela F, de Benedetti P, Goldberg SR, Neve K, Fuxe K, Agnati LF, Woods AS, Ferré S, Lluis C, Bouvier M, Franco R. Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. The Journal of Biological Chemistry. 278: 46741-9. PMID 12933819 DOI: 10.1074/Jbc.M306451200 |
0.43 |
|
2003 |
Franco R, Canals M, Marcellino D, Ferré S, Agnati L, Mallol J, Casadó V, Ciruela F, Fuxe K, Lluis C, Canela EI. Regulation of heptaspanning-membrane-receptor function by dimerization and clustering. Trends in Biochemical Sciences. 28: 238-43. PMID 12765835 DOI: 10.1016/S0968-0004(03)00065-3 |
0.401 |
|
Show low-probability matches. |